Article info

PDF

Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)

Authors

  1. Correspondence to Professor Zobair M Younossi; zobair.younossi{at}inova.org
View Full Text

Citation

Golabi P, Stepanova M, Pham HT, et al
Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)

Publication history

  • Received January 9, 2018
  • Revised February 28, 2018
  • Accepted March 2, 2018
  • First published March 20, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.